z-logo
open-access-imgOpen Access
Biosynthesis of fosfomycin in pseudomonads reveals an unexpected enzymatic activity in the metallohydrolase superfamily
Author(s) -
Max A. Simon,
Chayanid Ongpipattanakul,
Satish K. Nair,
Wilfred A. van der Donk
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2019863118
Subject(s) - fosfomycin , biochemistry , enzyme , biosynthesis , polyketide , microbiology and biotechnology , biology , chemistry , pseudomonas putida , antibiotics
Significance Fosfomycin is an antibiotic used for the treatment of cystitis. Its activity against both gram-positive and gram-negative pathogens has received strong recent interest. The compound is biosynthesized by both pseudomonads and streptomycetes via two different pathways that converge in the last step to form the natural product. This study investigated the biosynthesis of fosfomycin byPseudomonas and revealed an oxidative decarboxylation activity within this pathway. Structural and sequence analysis of the enzyme identified key residues important for its activity and demonstrated its role in the biosynthesis of other phosphonate natural products. This newly characterized protein family expands the chemical space of catalysis by metallohydrolase superfamily enzymes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom